2023 | Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy | 김광명 | Review |
2022 | Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy | 김광명 | Article |
2023 | Enhanced delivery of the phototherapeutic nanoparticles via hepatocyte overload | 김광명 | Article |
2023 | Fluorescence-Based Mono- and Multimodal Imaging for In Vivo Tracking of Mesenchymal Stem Cells | 김광명 | Review |
2022 | Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light | 김광명 | Article |
2023 | In situ albumin-binding and esterase-specifically cleaved BRD4-degrading PROTAC for targeted cancer therapy | 김광명 | Article |
2023 | In vivo toxicity evaluation of tumor targeted glycol chitosan nanoparticles in healthy mice: repeated high-dose of glycol chitosan nanoparticles potentially induce cardiotoxicity | 김광명 | Article |
2022 | Injectable Hydrogel-Based Combination Cancer Immunotherapy for Overcoming Localized Therapeutic Efficacy | 김광명 | Review |
2023 | Intracellular Glucose-Depriving Polymer Micelles for Antiglycolytic Cancer Treatment | 김광명 | Article |
2022 | Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity | 김광명 | Article |
2022 | Mesenchymal Stem Cell-Mediated Deep Tumor Delivery of Gold Nanorod for Photothermal Therapy | 김광명 | Article |
2023 | Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy | 김광명 | Article |
2022 | Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy | 김광명 | Article |
2024 | Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapy | 김광명 | Article |
2022 | Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity | 김광명 | Article |
2022 | Prediction the clinical EPR effect of nanoparticles in patient-derived xenograft models | 김광명 | Article |
2024 | Recent developments in chemodrug-loaded nanomedicines and their application in combination cancer immunotherapy | 김광명 | Review |
2023 | Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems | 김광명 | Review |
2023 | Thermally Managed, Injectable Optoelectronic Probe with Heat Dissipation Guide for Photodynamic Therapy | 김광명 | Article |
2022 | Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy | 김광명 | Article |